Suchergebnisse - "Hasselbalch, Hans Carl"

PubPharm (236)

91

Minimal residual disease after long-term interferon-alpha2 treatment : a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia vera

enthalten in: Leukemia & lymphoma | 2016

von Utke Rank, C. | Weis Bjerrum, O. | Larsen, T. | +4

92

Antecedent cardiovascular disease and autoimmunity in Philadelphia-negative chronic myeloproliferative neoplasms

enthalten in: Leukemia research | 2016

von Sørensen, A. | Hasselbalch, H.

93

The Danish National Chronic Myeloid Neoplasia Registry

enthalten in: Clinical epidemiology | 2016

von Bak, M. | Ibfelt, E. | Stauffer Larsen, T. | +7

94

A remarkable hematological and molecular response pattern in a patient with polycythemia vera during combination therapy with simvastatin and alendronate

enthalten in: Leukemia research reports | 2016

von Sørensen, A. | Kallenbach, K. | Hasselbalch, H.

95

A new internet-based tool for reporting and analysing patient-reported outcomes and the feasibility of repeated data collection from patients with myeloproliferative neoplasms

Erschienen: 2016

von Brochmann, N. | Zwisler, A. | Kjerholt, M. | +3

96

Ruxolitinib is manageable in patients with myelofibrosis and severe thrombocytopenia : a report on 12 Danish patients

enthalten in: Leukemia & lymphoma | 2016

von Bjørn, M. | Holmström, M. | Hasselbalch, H.

97

A 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic Myelofibrosis

enthalten in: PloS one | 2016

von Skov, V. | Burton, M. | Thomassen, M. | +15

98

Ruxolitinib is manageable in patients with myelofibrosis and severe thrombocytopenia: a report on 12 Danish patients

enthalten in: Leukemia & lymphoma | 2016

von Bjørn, M. | Holmström, M. | Hasselbalch, H.

99

Antecedent cardiovascular disease and autoimmunity in Philadelphia-negative chronic myeloproliferative neoplasms

enthalten in: Leukemia research | 2016

von Hasselbalch, H. | Sørensen, A.

100

Minimal residual disease after long-term interferon-alpha2 treatment: a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia vera

enthalten in: Leukemia & lymphoma | 2016

von Utke Rank, C. | Weis Bjerrum, O. | Larsen, T. | +4